Navigation Links
Repligen Announces ISO 9001:2000 Certification
Date:2/12/2009

WALTHAM, Mass., Feb. 12 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN), a global leader in the manufacture of recombinant Protein A products, announced today that the Company has received ISO 9001:2000 (ISO) certification, the international standard for best practices for manufacturing and quality systems. ISO certification was granted for the quality management system supporting the manufacture of products and related services underlying its Protein A business. Repligen has supplied Protein A products to the biopharmaceutical industry for more than 20 years and pursued ISO certification to demonstrate that its operations meet the high quality standard which has global acceptance within the industry.

"We are very proud to have received ISO certification for our Protein A business, a milestone that reinforces our longstanding commitment to quality and customer satisfaction," said Walter C. Herlihy, President and Chief Executive Officer of Repligen.

Repligen is the world's leading supplier of recombinant Protein A, a consumable used in the manufacture of therapeutic monoclonal antibodies. There are approximately 20 monoclonal antibodies that have received regulatory approval with more than 200 products in various stages of clinical development. The worldwide revenues from this class of drug were approximately $35 billion in 2008. Monoclonal antibodies are the largest and one of the fastest growing classes of drug in the biopharmaceutical industry.

ISO 9001:2000 is a quality management system standard that represents an international consensus on the best quality management practice. Created and published by the International Organization for Standardization, a network of the national standards institutes representing 160 countries, ISO standards define globally relevant management and process re
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
2. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
3. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
4. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
5. Repligen Announces Share Repurchase Program
6. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
7. Repligen Elects Earl Henry, M.D. to the Board of Directors
8. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
9. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
10. Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
11. Palatin Technologies Announces Receipt of $4.1 Million from AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... American Society of Association Executives (ASAE) announced its 2014 ... of the American Society of Anesthesiologists (ASA). , ... Power of A Gold Award, one of the top ... the betterment of the world through education on the ... improve anesthesia care. , ASA was also honored with ...
(Date:7/24/2014)... July 24, 2014 Pools and beaches are ... water can be dangerous, especially for small children, so ... safety. , According to the Centers for Disease Control and ... most at risk for water-related injuries and deaths. It’s important ... around water, so Amica is offering the following tips from ...
(Date:7/24/2014)... News Facts , Lexmark’s ... certification for compliance with Department of Defense (DoD) ... DoD Information Assurance Certification and Accreditation Process (DIACAP). ... the DoD as the Enterprise Clinical Imaging Archive, ... the U.S. Army Medical Materiel Agency. , DIACAP ...
(Date:7/24/2014)... July 24, 2014 A new study led ... into the interplay among bacteria, viruses and the immune ... men,s infectivity their potential to infect others ... produce large amounts of virus in their semen despite ... "compartmentalization," where different levels of the virus can be ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2
... may pride themselves on being highly evolved, most still ... choosing a mate, according to research by Indiana University ... and colleagues found that though individuals may claim otherwise, ... the much choosier of the sexes, leverage their looks ...
... the religious beliefs and practices of American physicians has ... is psychiatry. Among psychiatrists who have a religion, more ... are Protestant or Catholic, the two most common religions ... September 2007 issue of Psychiatric Services, also found that ...
... 12 to 19 years who received family-based treatment were ... those who received supportive psychotherapy, which explores the underlying ... the September issue of Archives of General Psychiatry, one ... a disabling eating disorder with a prevalence of 1 ...
... Deer Run, 360 White Deer Run Road, ... Treatment Gap of One Million Needing Treatment vs. 90,000 ... Obtaining Help, WDR Parent CRC Health Group CEO Dr. ... Officials, State Representatives, HARRISBURG, Pa., ...
... September 3 - QUANTEL has Entered Into ... the Company WaveLight Aesthetic GmbH A strong complementarity ... WaveLight AG, is,specialized in Dermatology/Aesthetic lasers. It is based ... estimated of approx. 10MEUR,for the fiscal year 2006/2007 ended ...
... schizophrenia, INDIANAPOLIS, Sept. 2 An investigational,phase II ... for the first time in humans a drug that ... antipsychotic activity. The study,was sponsored by Eli Lilly and ... - a randomized, double-blind, placebo-controlled clinical,trial - patients were ...
Cached Medicine News:Health News:Choosing a mate: what we really want 2Health News:Psychiatrists are the least religious of all physicians 2Health News:Psychiatrists are the least religious of all physicians 3Health News:Family-based treatment more effective than supportive psychotherapy in treating bulimia 2Health News:4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA 'National Model' Detox Center 2Health News:QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 3Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 4Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 5Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 6
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... Ohio, July 24, 2014  Mettler-Toledo International Inc. (NYSE: ... for 2014.  Provided below are the highlights: ... the quarter compared with the prior year. Reported sales ... , Net earnings per diluted share as reported ... quarter of 2013. Adjusted EPS was $2.57, an increase ...
(Date:7/24/2014)... THOUSAND OAKS, Calif. , July 24, 2014 ... will report its second quarter financial results on Tuesday, July ... The announcement will be followed by a conference call with ... call from Amgen will be Robert A. Bradway , ... senior management team. Live audio of the conference ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... Facility, VIENNA, Va., Aug. 14 CEL-SCI CORPORATION,(Amex: ... into an agreement with a,biomedical real estate group under ... facility for its cancer drug Multikine(R). The,financial value of ... is located near Baltimore, Maryland. Once fully built out ...
... ALTO, Calif., Aug. 15 CV Therapeutics,Inc. (Nasdaq: ... developed jointly,by the American College of Cardiology Foundation ... week,s issue of Circulation, state that,"ranolazine may be ... Ranexa(R) (ranolazine extended-release tablets) is indicated for the,treatment ...
Cached Medicine Technology:CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 2CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 4Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2
Steroid-eluting, screw-in pacing lead...
... one of the world's thinnest, ... a 7 F introducer, the ... designed to lower the incidence ... introduction in smaller, more tortuous ...
... Vitatron Crystalline Active fixation lead series ... new extendable retractable helix mechanism, specifically ... the pacemaker system, reducing the sensing ... The Crystalline Active fixation leads allow ...
... 6491 unipolar pediatric temporary pacing ... atrial and ventricular sensing and ... surgery. This temporary pacing lead ... the ideal lead for pediatric ...
Medicine Products: